Evonik is expanding its capacity to produce MetAMINO (DL-methionine) on Jurong Island, Singapore, by 40,000 metric tons to around 340,000 metric tons per year, said the company.
The high double-digit million euro investment in this further technological development is to reach target capacity by the third quarter of 2024.
At the core of the methionine strategy are the three production hubs in Singapore, Mobile (Alabama, USA) and Antwerp (Belgium). All three of Evonik’s world-scale plants are based on best-in-class technologies and are designed to grow with the expanding global market through modular expansions.
Evonik’s methionine plants in Singapore, which came on stream in 2014 and 2019, were already the largest production complex for DL-methionine in the world, with an annual capacity of around 300,000 metric tons of MetAMINO®.
The company has succeeded in maintaining its technology and cost leadership in DL-methionine for decades by continuously optimizing its processes and equipment:
These technological adjustments are an important building block in the sustainability strategy of the Nutrition & Care division. The carbon footprint of the additional volume will be reduced by 50% thanks to process improvement measures. This reduces the carbon footprint of the entire MetAMINO production in Singapore by 6%.